Scripps' technology has been licensed by a biotech company Romesberg co-founded, Synthorx Inc., that aims to make novel protein-based drugs.
News
- Expanding DNA's alphabet lets cells produce novel proteins
- bioAffinity Technologies Welcomes New Board Members
SAN ANTONIO, Nov. ... toward commercialization, bioAffinity will benefit from Dr. Squinto's 25-plus years of experience in the biotechnology industry.”.
- A snapshot of emerging technology patents that SA companies are waiting for
Dozens of companies across industries in San Antonio have filed for patent ... Biotechnology company Inspyr Therapeutics Inc. assigned a patent ...
- Botanical and Plant-derived Drugs: Global Markets
There are many botanical drug products in development, with a few in late-stage clinical trials. Promising candidates for commercialization include: SAN 007 (5% East Indian sandalwood oil in a cream formulation) from Santalis Pharmaceuticals (San Antonio, Texas), Oneness Biotech's WH-1…
- Scholarship program brings Mexican students to Alamo Colleges
... degree plans back home, take supplemental English classes, participate in leadership workshops, volunteer with Habitat for Humanity and the San Antonio Food Bank — and ... They have studied a range of disciplines including accounting, marketing, international affairs and biomedical…